Merck (MRK) Return on Sales (2009 - 2026)

Merck (MRK) has 18 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales fell 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q1 2026 per MRK's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q2 2024 and bottomed at 0.0% in Q2 2023.
• The 5-year median for Return on Sales is 0.0% (2023), against an average of 0.0%.
• The widest annual swing landed in 2024, when Return on Sales grew 1 bps; it then fell 1 bps in 2026.
• Tracing MRK's Return on Sales over 5 years: stood at 0.0% in 2022, then sank by 7871 bps to 0.0% in 2023, then surged by 386 bps to 0.0% in 2024, then dropped by 25 bps to 0.0% in 2025, then sank by 243 bps to 0.0% in 2026.
• Per Business Quant, the three latest MRK Return on Sales figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison